TCL Archive Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.” December 16, 2005
TCL Archive Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research January 4, 1991
TCL Archive NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis” May 7, 1993
